 | • レポートコード：QY20ST-05241 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の水痘生ワクチン市場について種類別（一価水痘ワクチン、水痘ワクチン）、用途別（水痘予防接種、帯状疱疹予防接種、はしか、おたふく風邪、風疹および水痘（MMRV）予防接種）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・水痘生ワクチン市場の概要 ・世界の主要地域別水痘生ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の水痘生ワクチン市場規模2015-2026：種類別（一価水痘ワクチン、水痘ワクチン） ・世界の水痘生ワクチン市場規模2015-2026：用途別（水痘予防接種、帯状疱疹予防接種、はしか、おたふく風邪、風疹および水痘（MMRV）予防接種） ・水痘生ワクチンの北米市場規模2015-2020 ・水痘生ワクチンのヨーロッパ市場規模2015-2020 ・水痘生ワクチンの中国市場規模2015-2020 ・水痘生ワクチンの日本市場規模2015-2020 ・水痘生ワクチンの東南アジア市場規模2015-2020 ・水痘生ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・水痘生ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・水痘生ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Varicella Live Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Varicella zoster is also known as Human alphaherpesvirus 3 and causes chicken pox and herpes zoster in humans. The infection caused by this virus can be prevented by the use of vaccinations that are specially formulated to provide immunity against the virus. There are mainly two types of vaccinations available to provide immunity against varicella zoster such as monovalent varicella vaccine and combination varicella vaccine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Varicella Live Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Varicella Live Vaccine industry.
Based on our recent survey, we have several different scenarios about the Varicella Live Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2361 million in 2019. The market size of Varicella Live Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Varicella Live Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Varicella Live Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Varicella Live Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Varicella Live Vaccine market. The report also includes nautical information, where it shows Varicella Live Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Varicella Live Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Varicella Live Vaccine market.
Geographical Analysis:
Based on region, the global Varicella Live Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Varicella Live Vaccine market are
Bio-Med Pvt. Limited
Changchun BCHT Biotechnology
Emcure Pharmaceuticals
GlaxoSmithKline
GC Pharma
Merck & Co. Inc.
Mitsubishi Tanabe Pharma
Novo Medi Sciences
Sanofi
Takeda Pharmaceutical Company Limited.
Segment by Type
Monovalent Varicella Vaccine
Combination Varicella Vaccine
Segment by Application
Chickenpox Immunization
Herpes Zoster Immunization
Measles, Mumps, Rubella and Varicella (MMRV) Immunization
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Varicella Live Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Varicella Live Vaccine market.
• The market share of the global Varicella Live Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Varicella Live Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Varicella Live Vaccine market.
1 Varicella Live Vaccine Market Overview
1.1 Varicella Live Vaccine Product Scope
1.2 Varicella Live Vaccine Segment by Type
1.2.1 Global Varicella Live Vaccine Sales by Type (2020-2026)
1.2.2 Monovalent Varicella Vaccine
1.2.3 Combination Varicella Vaccine
1.3 Varicella Live Vaccine Segment by Application
1.3.1 Global Varicella Live Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Chickenpox Immunization
1.3.3 Herpes Zoster Immunization
1.3.4 Measles, Mumps, Rubella and Varicella (MMRV) Immunization
1.4 Varicella Live Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Varicella Live Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Varicella Live Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Varicella Live Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Varicella Live Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Varicella Live Vaccine Industry
1.5.1.1 Varicella Live Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Varicella Live Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact
2 Varicella Live Vaccine Estimate and Forecast by Region
2.1 Global Varicella Live Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Varicella Live Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Varicella Live Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Varicella Live Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Varicella Live Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.3 China Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.6 India Varicella Live Vaccine Estimates and Projections (2015-2026)
3 Global Varicella Live Vaccine Competition Landscape by Players
3.1 Global Top Varicella Live Vaccine Players by Sales (2015-2020)
3.2 Global Top Varicella Live Vaccine Players by Revenue (2015-2020)
3.3 Global Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)
3.4 Global Varicella Live Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Varicella Live Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Varicella Live Vaccine Players (Opinion Leaders)
4 Global Varicella Live Vaccine Market Size by Type
4.1 Global Varicella Live Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Varicella Live Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Varicella Live Vaccine Price by Type (2014-2020)
4.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Varicella Live Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Live Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Varicella Live Vaccine Price Forecast by Type (2021-2026)
5 Global Varicella Live Vaccine Market Size by Application
5.1 Global Varicella Live Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Varicella Live Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Varicella Live Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Varicella Live Vaccine Price by Application (2015-2020)
5.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Varicella Live Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Live Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Live Vaccine Price Forecast by Application (2021-2026)
3 North America Varicella Live Vaccine Market Facts & Figures
3.2 North America Varicella Live Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Varicella Live Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Varicella Live Vaccine Sales Market Share by Application (2015-2020)
4 Europe Varicella Live Vaccine Market Facts & Figures
4.2 Europe Varicella Live Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Varicella Live Vaccine Sales Market Share by Application (2015-2020)
5 China Varicella Live Vaccine Market Facts & Figures
5.2 China Varicella Live Vaccine Sales Market Share by Company (2015-2020)
5.3 China Varicella Live Vaccine Sales Market Share by Type (2015-2020)
5.4 China Varicella Live Vaccine Sales Market Share by Application (2015-2020)
6 Japan Varicella Live Vaccine Market Facts & Figures
6.2 Japan Varicella Live Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Varicella Live Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Varicella Live Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Varicella Live Vaccine Market Facts & Figures
7.2 Southeast Asia Varicella Live Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Varicella Live Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Varicella Live Vaccine Sales Market Share by Application (2015-2020)
8 India Varicella Live Vaccine Market Facts & Figures
8.2 India Varicella Live Vaccine Sales Market Share by Company (2015-2020)
8.3 India Varicella Live Vaccine Sales Market Share by Type (2015-2020)
8.4 India Varicella Live Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Varicella Live Vaccine Business
12.1 Bio-Med Pvt. Limited
12.1.1 Bio-Med Pvt. Limited Varicella Live Vaccine Corporation Information
12.1.2 Bio-Med Pvt. Limited Varicella Live Vaccine Business Overview and Total Revenue
12.1.3 Bio-Med Pvt. Limited Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bio-Med Pvt. Limited Varicella Live Vaccine Products Offered
12.1.5 Bio-Med Pvt. Limited Recent Development
12.2 Changchun BCHT Biotechnology
12.2.1 Changchun BCHT Biotechnology Varicella Live Vaccine Corporation Information
12.2.2 Changchun BCHT Biotechnology Varicella Live Vaccine Business Overview and Total Revenue
12.2.3 Changchun BCHT Biotechnology Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Changchun BCHT Biotechnology Varicella Live Vaccine Products Offered
12.2.5 Changchun BCHT Biotechnology Recent Development
12.3 Emcure Pharmaceuticals
12.3.1 Emcure Pharmaceuticals Varicella Live Vaccine Corporation Information
12.3.2 Emcure Pharmaceuticals Varicella Live Vaccine Business Overview and Total Revenue
12.3.3 Emcure Pharmaceuticals Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Emcure Pharmaceuticals Varicella Live Vaccine Products Offered
12.3.5 Emcure Pharmaceuticals Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Varicella Live Vaccine Corporation Information
12.4.2 GlaxoSmithKline Varicella Live Vaccine Business Overview and Total Revenue
12.4.3 GlaxoSmithKline Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Varicella Live Vaccine Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 GC Pharma
12.5.1 GC Pharma Varicella Live Vaccine Corporation Information
12.5.2 GC Pharma Varicella Live Vaccine Business Overview and Total Revenue
12.5.3 GC Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GC Pharma Varicella Live Vaccine Products Offered
12.5.5 GC Pharma Recent Development
12.6 Merck & Co. Inc.
12.6.1 Merck & Co. Inc. Varicella Live Vaccine Corporation Information
12.6.2 Merck & Co. Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.6.3 Merck & Co. Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co. Inc. Varicella Live Vaccine Products Offered
12.6.5 Merck & Co. Inc. Recent Development
12.7 Mitsubishi Tanabe Pharma
12.7.1 Mitsubishi Tanabe Pharma Varicella Live Vaccine Corporation Information
12.7.2 Mitsubishi Tanabe Pharma Varicella Live Vaccine Business Overview and Total Revenue
12.7.3 Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mitsubishi Tanabe Pharma Varicella Live Vaccine Products Offered
12.7.5 Mitsubishi Tanabe Pharma Recent Development
12.8 Novo Medi Sciences
12.8.1 Novo Medi Sciences Varicella Live Vaccine Corporation Information
12.8.2 Novo Medi Sciences Varicella Live Vaccine Business Overview and Total Revenue
12.8.3 Novo Medi Sciences Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novo Medi Sciences Varicella Live Vaccine Products Offered
12.8.5 Novo Medi Sciences Recent Development
12.9 Sanofi
12.9.1 Sanofi Varicella Live Vaccine Corporation Information
12.9.2 Sanofi Varicella Live Vaccine Business Overview and Total Revenue
12.9.3 Sanofi Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Varicella Live Vaccine Products Offered
12.9.5 Sanofi Recent Development
12.10 Takeda Pharmaceutical Company Limited.
12.10.1 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Corporation Information
12.10.2 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Business Overview and Total Revenue
12.10.3 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Products Offered
12.10.5 Takeda Pharmaceutical Company Limited. Recent Development
13 Varicella Live Vaccine Manufacturing Cost Analysis
13.1 Varicella Live Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Varicella Live Vaccine
13.4 Varicella Live Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Varicella Live Vaccine Distributors List
14.3 Varicella Live Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Varicella Live Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Varicella Live Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Varicella Live Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Varicella Live Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Varicella Live Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Varicella Live Vaccine Sales (M Doses) by Region (2015-2020)
Table 10. Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Varicella Live Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Varicella Live Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Varicella Live Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Varicella Live Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Varicella Live Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Varicella Live Vaccine (M Doses) of Key Companies (2015-2020)
Table 18. Global Varicella Live Vaccine Sales Share by Company (2015-2020)
Table 19. Global Varicella Live Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Varicella Live Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Varicella Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)
Table 22. Global Varicella Live Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Varicella Live Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Varicella Live Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Varicella Live Vaccine Players
Table 27. Global Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 28. Global Varicella Live Vaccine Sales Share by Type (2015-2020)
Table 29. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Varicella Live Vaccine Price (M Doses) by Type (2015-2020)
Table 31. Global Varicella Live Vaccine Sales Share by Type (2021-2026)
Table 32. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Varicella Live Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Varicella Live Vaccine Price (M Doses) by Type (2021-2026)
Table 35. Global Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 36. Global Varicella Live Vaccine Sales Share by Application (2015-2020)
Table 37. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Varicella Live Vaccine Price (M Doses) by Application (2015-2020)
Table 39. Global Varicella Live Vaccine Sales (M Doses) by Application (2021-2026)
Table 40. Global Varicella Live Vaccine Sales Share by Application (2021-2026)
Table 41. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Varicella Live Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Varicella Live Vaccine Price (M Doses) by Application (2021-2026)
Table 44. United States Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 45. United States Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 47. United States Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 49. United States Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 51. Europe Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 53. Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 55. Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 57. China Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 59. China Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 61. China Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 63. Japan Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 65. Japan Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 67. Japan Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Varicella Live Vaccine Sales (M Doses) by Company (2015-2020)
Table 75. India Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Varicella Live Vaccine Sales (M Doses) by Type (2015-2020)
Table 77. India Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Varicella Live Vaccine Sales (M Doses) by Application (2015-2020)
Table 79. India Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 80. Bio-Med Pvt. Limited Corporation Information
Table 81. Bio-Med Pvt. Limited Description and Business Overview
Table 82. Bio-Med Pvt. Limited Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Bio-Med Pvt. Limited Varicella Live Vaccine Product
Table 84. Bio-Med Pvt. Limited Recent Development
Table 85. Changchun BCHT Biotechnology Corporation Information
Table 86. Changchun BCHT Biotechnology Description and Business Overview
Table 87. Changchun BCHT Biotechnology Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Changchun BCHT Biotechnology Varicella Live Vaccine Product
Table 89. Changchun BCHT Biotechnology Recent Development
Table 90. Emcure Pharmaceuticals Corporation Information
Table 91. Emcure Pharmaceuticals Description and Business Overview
Table 92. Emcure Pharmaceuticals Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Emcure Pharmaceuticals Varicella Live Vaccine Product
Table 94. Emcure Pharmaceuticals Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Varicella Live Vaccine Product
Table 99. GlaxoSmithKline Recent Development
Table 100. GC Pharma Corporation Information
Table 101. GC Pharma Description and Business Overview
Table 102. GC Pharma Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. GC Pharma Varicella Live Vaccine Product
Table 104. GC Pharma Recent Development
Table 105. Merck & Co. Inc. Corporation Information
Table 106. Merck & Co. Inc. Description and Business Overview
Table 107. Merck & Co. Inc. Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Merck & Co. Inc. Varicella Live Vaccine Product
Table 109. Merck & Co. Inc. Recent Development
Table 110. Mitsubishi Tanabe Pharma Corporation Information
Table 111. Mitsubishi Tanabe Pharma Description and Business Overview
Table 112. Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Mitsubishi Tanabe Pharma Varicella Live Vaccine Product
Table 114. Mitsubishi Tanabe Pharma Recent Development
Table 115. Novo Medi Sciences Corporation Information
Table 116. Novo Medi Sciences Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Novo Medi Sciences Description and Business Overview
Table 118. Novo Medi Sciences Varicella Live Vaccine Product
Table 119. Novo Medi Sciences Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Sanofi Description and Business Overview
Table 123. Sanofi Varicella Live Vaccine Product
Table 124. Sanofi Recent Development
Table . Takeda Pharmaceutical Company Limited. Corporation Information
Table . Takeda Pharmaceutical Company Limited. Description and Business Overview
Table . Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Product
Table . Takeda Pharmaceutical Company Limited. Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Varicella Live Vaccine Distributors List
Table 133. Varicella Live Vaccine Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Live Vaccine Product Picture
Figure 2. Global Varicella Live Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Varicella Live Vaccine Market Share by Application in 2020 & 2026
Figure 6. Chickenpox Immunization Examples
Figure 7. Herpes Zoster Immunization Examples
Figure 8. Measles, Mumps, Rubella and Varicella (MMRV) Immunization Examples
Figure 9. Global Varicella Live Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 10. Global Varicella Live Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Varicella Live Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Varicella Live Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Varicella Live Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Varicella Live Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 16. Europe Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Varicella Live Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Varicella Live Vaccine Players Market Share by Revenue in Varicella Live Vaccine 2015 & 2019
Figure 27. Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Varicella Live Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Varicella Live Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Varicella Live Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Varicella Live Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 33. United States Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 37. China Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 38. China Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 39. China Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 46. India Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 47. India Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 48. India Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 49. Bio-Med Pvt. Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Changchun BCHT Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Emcure Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. GC Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novo Medi Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Pharmaceutical Company Limited. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Varicella Live Vaccine
Figure 61. Manufacturing Process Analysis of Varicella Live Vaccine
Figure 62. Varicella Live Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…- 水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 水痘弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Varicella Attenuated Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measles Vaccine market report…
- 新型コロナウイルス感染症用ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Coronavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…